Discover a new way to find and share stories you'll love… Learn about Reading Desk

All Blogs / Industries / Medical / Pharmaceutical / Popular

Molecular Printing of Drug Molecules. Say What?

Here we have one of the oddest papers to appear in Drug Discovery Today, which is saying something. The journal has always ranged wider than some of the others in this space, but this is the furthest afield I've seen to date. The title...Show More Summary

2013’s Top 50 Retail Pharmacies, according to Drug Store News

Drug Store News (DSN) just released it latest rundown of the top pharmacy retailers in the powerfully-titled POWERx Top 50 list. Click here for for this free download. I highly recommend the POWERx list to anyone who competes with, sell to, or interacts with retail pharmacies. Show More Summary

Days Off

I'm going to be traveling on Wednesday and Thursday, so blogging will resume again here for Friday morning. This means that something completely insane will no doubt occur in the chemistry/drug discovery world sometime Wednesday afternoon, but it can't be helped. The Pfizer/Disney merger will have to wait until Friday morning for comment from me!

Shuffling the Departments

So word comes this morning of some big transactions between Novartis, GlaxoSmithKline, and Eli Lilly: Novartis said it had agreed to buy GlaxoSmithKline's oncology products for $14.5 billion, while selling to GSK its vaccines, excluding...Show More Summary

Funding Undergraduate Summer Research

I wanted to mention another crowdfunded organic chemistry effort, this one on a small (and useful) scale. A former colleague of mine, Brent Chandler, is an assistant professor of chemistry at Illinois College, and he's working with undergraduates in organic synthesis. Show More Summary

J. Appl. Drivel or Gibberish Lett.? Choices, Choices.

People keep hoaxing the predatory "scholarly" publishers out there, and the publishers keep falling for whatever drivel is slung at them. Here's the latest example from a reporter at the Ottawa Citizen, Tom Spears. He molded a pile of...Show More Summary

For 2013, Pharmacist Salaries Rise Yet Again For This Family-Friendly Occupation

Time for our exclusive annual analysis of pharmacist salaries, based on the Bureau of Labor Statistics’ (BLS) latest 2013 Occupational Employment Statistics (OES). Once again, pharmacist salaries grew faster than overall U.S. wages.Show More Summary

Upcoming AdComms by Subject Matter

In prior years, near the end of a calendar year, FDA would put up a schedule of Tentative Advisory Committee Meetings with tentative meeting dates scheduled for each Advisory Committee.  This year, however, the calendar went up, but very few … Continue reading ?

Pharmaceutical Wholesalers: Business Strategies and Financial Economics

Drug Channels Institute (DCI) is pleased to announce the release of our updated Pharmaceutical Wholesalers: Business Strategies and Financial Economics e-learning module. Click here to view an excerpt of this module.This e-learning module...Show More Summary

Pfizer Walks Again By Night

So the Sunday Times came out with a story saying that Pfizer has attempted a bid for AstraZeneca. This is something of a surprise, at least for me. Pfizer has most certainly done things like this in the past, but I was under the impression that current CEO Ian Read had sworn off the practice. Show More Summary

Is FDA Seeing What We're Seeing with Its Old-School Web Browsers? Klick Health Wants to Know

In comments submitted to the FDA regarding recent social media guidance (read "FDA Publishes First Piece of Long-Awaited Social Media Guidance" for background), Klick Health -- an interactive agency that has pharma clients -- asked a lot of questions. Show More Summary

Warning and NOV Letter Summary – 1st Quarter 2014

Each quarter, I provide an overview of the most recent Warning and NOV letters from OPDP to gain insight into any lessons learned and to look at overall trends.  But this quarter, it is really slim pickings.  More than slim … Continue reading ?


Pfizer mulls $100 bln bid for AstraZeneca - report (Reuters) - U.S. pharmaceutical giant Pfizer has approached British rival AstraZeneca to propose a 60 billion pound ($101 billion) takeover, the Sunday Times reported on Sunday. TheShow More Summary

Free samples of prescription drugs are costly to patients, study says

By Karen KaplanApril 16, 2014, 3:42 p.m.Free samples of prescription drugs may seem like a great deal for patients. But even when doctors think they’re doing patients a favor by handing out the freebies, the real beneficiaries are the...Show More Summary

What Pharma Can Learn from the CPG Industry About Social Media: If You "Like" Me, You Can't Sue Me!

The social networking savvy of consumer packaged goods (CPG) industry is often cited by pharma marketing consultants as something the pharmaceutical industry should emulate. Here's what one interactive agency -- picked at random viaShow More Summary

Download the Armada Specialty Pharmacy Summit & Expo App

Below is a message from our friends at Armada, who developed a cool smartphone app for the upcoming Armada Specialty Pharmacy Summit & Expo.After using the app for a few days, I can personally recommend it to everyone who is attending. Show More Summary

Weekly Roundup – 4.18.14

There were audible gasps all over the Internet from people experiencing yet more snow this week – the week of Easter break for many.  Freeze warnings here threatened my young herbs planted only a few days before over a warm … Continue reading ?

Digital Health Coalition Urges FDA to Launch a Social Media "Laboratory" to Ensure Adequate Guidance Progress

In comments submitted to the FDA regarding recent social media guidance (read "FDA Publishes First Piece of Long-Awaited Social Media Guidance" for background), the Digital Health Coalition (DHC) -- comprised mostly of pharma companies...Show More Summary

Gitcher SF5 Groups Right Here

I think that several of us in medicinal chemistry have been keeping our eyes out for a chance to work in a pentafluorosulfanyl (SF5) group. I know I have - I actually have a good-sized folder on the things, and some of the intermediates as well, but I've never found the right opportunity. Show More Summary

BIO Mimics PhRMA's Comments to FDA Regarding Recent SM Guidance But Is More Polite About It

In its opening remarks in comments submitted to the FDA regarding recent Draft Guidance ("Guidance for Industry: Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human...Show More Summary

Copyright © 2011 Regator, LLC